SNES:NSC-SenesTech Inc. (USD)

COMMON STOCK | Specialty Chemicals | NASDAQ Capital Market

Last Closing

USD 0.7877

Change

+0.03 (+3.67)%

Market Cap

USD 0.09B

Volume

0.04M

Analyst Target

USD 4.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

SenesTech Inc is a biotech platform and research company. The Company is engaged in developing technology for managing animal pest populations through fertility control.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-01 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
LIN Linde plc Ordinary Shares

N/A

USD 208.82B
BCPC Balchem Corporation

N/A

USD 5.07B
IOSP Innospec Inc

N/A

USD 3.28B
WDFC WD-40 Company

N/A

USD 3.25B
HWKN Hawkins Inc

N/A

USD 1.60B
LWLG Lightwave Logic Inc

N/A

USD 0.47B
HDSN Hudson Technologies Inc

N/A

USD 0.41B
GEVO Gevo Inc

N/A

USD 0.17B
NTIC Northern Technologies

N/A

USD 0.17B
ALTO Alto Ingredients Inc

N/A

USD 0.13B

ETFs Containing SNES

DXSD:F 5.56 % 0.00 %

N/A

N/A
DXSD:XETRA 5.56 % 0.00 %

N/A

N/A
EYED:LSE iShares MSCI Europe Energ.. 2.61 % 0.00 %

N/A

USD 0.02B
ENGE:LSE SPDR® MSCI Europe Energy.. 2.61 % 0.00 %

N/A

USD 1.07B
STNX:SW SPDR® MSCI Europe Energy.. 2.61 % 0.00 %

N/A

USD 1.08B
ESIE:LSE iShares MSCI Europe Energ.. 2.58 % 0.00 %

N/A

USD 0.14B
ESIE:XETRA iShares MSCI Europe Energ.. 2.45 % 0.00 %

N/A

USD 0.15B
SXEPEX:SW iShares STOXX Europe 600 .. 2.27 % 0.00 %

N/A

USD 0.55B
ENGY:LSE SPDR® MSCI Europe Energy.. 2.19 % 0.00 %

N/A

USD 1.06B
CRAK VanEck Oil Refiners ETF 0.00 % 0.60 %

N/A

USD 0.04B
XSER:LSE 0.00 % 0.00 %

N/A

N/A
STN:PA SPDR® MSCI Europe Energy.. 0.00 % 0.00 %

N/A

USD 1.09B
EXH1:F iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

USD 0.55B
SMLU:F 0.00 % 0.00 %

N/A

N/A
SPYN:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 1.09B
EXH1:XETRA iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

USD 0.73B
SPYN:XETRA SPDR® MSCI Europe Energy.. 0.00 % 0.00 %

N/A

USD 0.99B

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange (NASDAQ Capital Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -37.98% 28% F 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -37.98% 28% F 14% F
Trailing 12 Months  
Capital Gain -95.03% 13% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -95.03% 13% F 2% F
Trailing 5 Years  
Capital Gain -99.64% 9% A- 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.64% 9% A- 2% F
Average Annual (5 Year Horizon)  
Capital Gain -27.31% 25% F 13% F
Dividend Return -27.31% 25% F 13% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 83.80% 25% F 19% F
Risk Adjusted Return -32.59% 31% F 26% F
Market Capitalization 0.09B 13% F 4% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative earnings

The company had negative total earnings in the most recent four quarters.